h1

001020778 001__ 1020778
001020778 005__ 20260202101527.0
001020778 0247_ $$2ISSN$$a0931-0509
001020778 0247_ $$2ISSN$$a1460-2385
001020778 0247_ $$2WOS$$aWOS:001598327300022
001020778 0247_ $$2doi$$a10.1093/ndt/gfaf116.0202
001020778 037__ $$aRWTH-2025-09231
001020778 041__ $$aEnglish
001020778 082__ $$a610
001020778 1001_ $$0P:(DE-82)IDM05844$$aFlöge, Jürgen$$b0$$urwth
001020778 1112_ $$a62. ERA Congress$$cVienna$$d2025-06-04 - 2025-06-07$$gERA 2025$$wAustria
001020778 245__ $$aEffects of sparsentan after maximized angiotensin receptor blocker (ARB) treatment in patients with iga nephropathy (IgAN) in the PROTECT trial free$$honline, print
001020778 260__ $$aOxford$$bOxford Univ. Press$$c2025
001020778 300__ $$ai402-i403
001020778 3367_ $$00$$2EndNote$$aJournal Article
001020778 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract
001020778 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001020778 3367_ $$2BibTeX$$aARTICLE
001020778 3367_ $$2DRIVER$$aarticle
001020778 3367_ $$2DataCite$$aOutput Types/Journal article
001020778 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001020778 500__ $$aHefttitel: 62nd ERA Congress, 4-7 June 2025: Congress Abstracts
001020778 588__ $$aDataset connected to CrossRef, Journals: publications.rwth-aachen.de
001020778 591__ $$aCzech Republic
001020778 591__ $$aGermany
001020778 591__ $$aSweden
001020778 591__ $$aUSA
001020778 7001_ $$aRizk, Dana$$b1
001020778 7001_ $$aPreciado, Priscila$$b2
001020778 7001_ $$aRovin, Brad$$b3
001020778 7001_ $$aMoody, Stephanie$$b4
001020778 7001_ $$aGeletka, Rob$$b5
001020778 7001_ $$aMercer, Alex$$b6
001020778 7001_ $$aHendry, Bruce$$b7
001020778 7001_ $$aKomers, Radko$$b8
001020778 7001_ $$aTesar, Vladimir$$b9
001020778 773__ $$0PERI:(DE-600)1465709-0$$a10.1093/ndt/gfaf116.0202$$nSupplement_3$$pgfaf116.0202$$tNephrology, dialysis, transplantation$$v40$$x1460-2385$$y2025
001020778 909CO $$ooai:publications.rwth-aachen.de:1020778$$pVDB
001020778 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM05844$$aRWTH Aachen$$b0$$kRWTH
001020778 9141_ $$y2025
001020778 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEPHROL DIAL TRANSPL : 2022$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2025-01-02$$wger
001020778 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-02
001020778 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEPHROL DIAL TRANSPL : 2022$$d2025-01-02
001020778 9201_ $$0I:(DE-82)531020-2_20140620$$k531020-2 ; 932610$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Nephrologie und Immunologie)$$x0
001020778 961__ $$c2025-11-04T09:58:29.096471$$x2025-11-04T09:58:29.096471$$z2025-11-04T09:58:29.096471
001020778 980__ $$aI:(DE-82)531020-2_20140620
001020778 980__ $$aUNRESTRICTED
001020778 980__ $$aVDB
001020778 980__ $$aabstract
001020778 980__ $$ajournal